Business Context and Reporting Period
This Form 8-K filing by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) reports on the Annual Meeting of Stockholders held on June 7, 2018. The company is incorporated in Delaware and maintains its principal executive offices in Irvine, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on two primary proposals:
- Election of Directors: Six directors were elected to serve until the 2019 annual meeting. Notably, Kimble L. Jenkins received a significantly higher number of withheld votes (699,685) compared to the other five nominees, who each received approximately 10,460 to 10,485 withheld votes. All nominees received over 4.2 million "For" votes.
- Ratification of Auditors: Stockholders ratified the appointment of Cherry Bekaert LLP as the independent registered public accounting firm for the year ending December 31, 2018. The proposal passed with 7,488,460 votes "For" and 101,648 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting outcomes.
Investor Verification Checklist
- Verify the significant disparity in withheld votes for director nominee Kimble L. Jenkins compared to other board members.
- Confirm the total number of shares eligible to vote versus the number of broker non-votes (2,668,841) to assess shareholder engagement levels.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.